pharma news today obesity drugs glp-1 september 2025 Overdoses Are Rising as Telehealth Weight-Loss Prescriptions Boom ISPOR 2025: Exploring reasons for
Description
Both, SGLT2 inhibitors and GLP1 receptor agonists, had similar effect on MACE reduction, but SGLT2 inhibitors have far more benefits in patients with heart failure
GLP-1s have rapidly become first-line therapy for many patients because they directly address the underlying driver: excess fat deposition in the liver
Exercise also preserves lean muscle mass during weight loss, which is critical for maintaining healthy hormone production and overall body composition
The GLP-1 plotter tool can help visualize your dosing patterns over time
